tech:

taffy

Motorola Electrify 2, Defy XT Launch On US Cellular

[Techtaffy Newsdesk]

U.S. Cellular and Motorola Mobility are launching two Android-powered smartphones. The Motorola Electrify 2, the next generation of the popular Electrify that runs on Android 4.0 Ice Cream Sandwich, will be available online on August 1 and in stores on August 2. Additionally, Motorola Defy XT will be available online and in stores on August 3.

With a slim 8.4 millimeter design, Motorola Electrify 2 is Kevlar-strong and features an invisible splash-guard coating to protect from spills. The phone features a 1.2GHz dual-core processor and 4.3-inch ColorBoost  display. The phone has a rear-facing 8 megapixel camera with LED flash and a 1080p HD camcorder. It’s also the first U.S. Cellular device to include Smartactions, a free Motorola app that can help extend battery life as well as intelligently automate routine, everyday tasks.

Motorola Defy XT is water-resistant, dustproof and comes with a scratch-resistant 3.7-inch touchscreen. The phone features a 5 megapixel camera and a front facing webcam for video chats.

[Image: Motorola Electrify]

Just in

Windows 11 Start menu ads are now rolling out to everyone — The Verge

Microsoft is starting to enable ads inside the Start menu on Windows 11 for all users, writes Tom Warren. 

Biden signs TikTok ‘ban’ bill into law, starting the clock for ByteDance to divest it — The Verge

President Joe Biden signed a foreign aid package that includes a bill that would ban TikTok if China-based parent company ByteDance fails to divest the app within a year, writes Lauren Feiner.

IBM to acquire HashiCorp for $6.4B

IBM and HashiCorp have entered into an agreement for IBM to acquire HashiCorp, a provider of infrastructure and security management products, for $6.4 billion.

Oracle is moving its world headquarters to Nashville to be closer to health-care industry — CNBC

Oracle Chairman Larry Ellison said Tuesday that the company is moving its world headquarters to Nashville, Tennessee, to be closer to a major health-care epicenter, writes Ashley Capoot.